Berlin goes MedTech Toronto

As the leading event in Canada's and the USA’s medical technology sector, The Medtech Conference in Toronto offers a dynamic platform for startups, SMEs, accelerators, investors, and industry leaders to establish important connections, share…

2 Min
More

MSD launches IDEA Studios in Berlin

IDEA Studios will be strategically located in Asian and European innovation hubs to partner closely with early-stage companies focused on improving patient care

5 Min
More

In severe COVID-19, neutrophils work overtime

Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns…

4 Min
More

Interview | Uirá Souto Melo, PhD CEO and Co-Founder of Lucid Genomics

„Berlin is the best place for AI startups in Germany”

4 Min
More

New perspectives for patients: National Strategy for Gene and Cell Therapies presented to the BMBF

Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the…

5 Min
More

Tacalyx extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs

BERLIN, Germany, June 11, 2024 – Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announces the extension of its seed financing to over €14 M. This extension…

3 Min
More

QS World University Rankings 2025: Freie Universität Berlin Places Fourth among German Universities

University ranks ninety-seventh in the world. According to this year’s QS World University Rankings, Freie Universität Berlin is among the top four universities in Germany. The rankings are published annually by higher education consulting firm…

1 Min
More

BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel

• Regenerative Medicine Advanced Therapy (RMAT) designation follows phase I clinical trial results demonstrating that bemdaneprocel is well tolerated with no major safety issues through 18 months

• Bemdaneprocel is the most clinically advanced…

7 Min
More

Genetic mosaicism more common than thought

Blood stem cells from healthy people carry major chromosomal alterations, a study in “Nature Genetics” by researchers at the Max Delbrück Center and the European Molecular Biology Laboratory finds. The discovery suggests that we are all genetic…

4 Min
More

Klosterfrau-Group Award for Research of Airway Diseases in Childhood 2025

Application starts on June 3, 2024 and ends on November 22, 2024

3 Min
More
Show more items